These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Sampathirao N; Basu S J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019 [TBL] [Abstract][Full Text] [Related]
7. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors. Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704 [TBL] [Abstract][Full Text] [Related]
8. Bilateral Orbital Soft-Tissue Metastases from Renal Neuroendocrine Tumor: Successful Theranostic Application of Parghane RV; Basu S J Nucl Med Technol; 2019 Jun; 47(2):171-172. PubMed ID: 30139884 [TBL] [Abstract][Full Text] [Related]
9. 68Ga DOTATATE PET/CT Imaging of Elastofibroma Dorsi. Ishiyama M; Vesselle H Clin Nucl Med; 2018 May; 43(5):e154-e155. PubMed ID: 29485441 [TBL] [Abstract][Full Text] [Related]
10. 68Ga-DOTATATE PET/CT Uptake in Prostate With an Incidental Finding of Prostatic Acinar Adenocarcinoma and Metastatic Neuroendocrine Cancer to the Liver. Nisar MU; Costa DN; Jia L; Öz OK; de Blanche L Clin Nucl Med; 2021 Aug; 46(8):e428-e430. PubMed ID: 34034323 [TBL] [Abstract][Full Text] [Related]
11. 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma. Chen EJ; Tan TH; Chew MT; Chye PC Clin Nucl Med; 2020 Jul; 45(7):e317-e319. PubMed ID: 32404702 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors. Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446 [TBL] [Abstract][Full Text] [Related]